Results 141 to 150 of about 1,076,076 (217)

Emergence of OXA-484, an OXA-48–type beta-lactamase, in Switzerland

Journal of Global Antimicrobial Resistance, 2023
Jacqueline Findlay, Juan Bosch Duran, Laurent Poirel, Patrice Nordmann   +3 more
doaj   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Hydrogen-Bonding Changes Cause Differences in Imipenem Breakdown Activity in OXA-48 Variants. [PDF]

J Chem Inf Model
Wang D, Mulholland AJ, Spencer J, van der Kamp MW.   +3 more
europepmc   +1 more source

Genetic and biochemical characterization of OXA-405, an OXA-48-Type extended-spectrum β-lactamase without significant carbapenemase activity

, 2015
The epidemiology of carbapenemases worldwide is showing that OXA-48 variants are becoming the predominant carbapenemase type in Enterobacteriaceae in many countries.
Dortet, Laurent, Naas, Thierry, Tandé, Didier, Oueslati, Saoussen, Nordmann, Patrice, Jeannot, Katy   +5 more
core  

Predominant Distribution of OXA-48-Like Carbapenemase in Fecal Colonization

Antimicrobial Agents and Chemotherapy, 2020
Wen-Li, Yuan, Jia-Li, Xu, Lin, Guo, Qiong-Fang, Deng, De-Yao, Deng   +4 more
openaire   +3 more sources

Improved hydrolysis of piperacillin by OXA-48-like R214G variants, a selective advantage under piperacillin-tazobactam exposure. [PDF]

Antimicrob Agents Chemother
Nermont R, Oueslati S, Aumont-Nicaise M, Retailleau P, Iorga BI, Naas T.   +5 more
europepmc   +1 more source

Phage-meropenem synergy against OXA-48-producing Klebsiella pneumoniae clinical isolates. [PDF]

NPJ Antimicrob Resist
Cantallops I, Ferriol-González C, Barcos-Rodríguez T, Fernández-Cuenca F, Cañada-García JE, García-Cobos S, Domingo-Calap P.   +6 more
europepmc   +1 more source

Unraveling Cefiderocol Resistance in NDM- and OXA-48-like Co-Producing <i>Klebsiella pneumoniae</i> Isolates Through Integrated Genomic and Phenotypic Analysis. [PDF]

Antibiotics (Basel)
Ambretti S, Cetatean R, Secci B, Landi J, Cantiani A, Foschi C.   +5 more
europepmc   +1 more source

Carbapenem and colistin-resistant <i>Klebsiella pneumoniae</i> co-producing NDM-5 and OXA-48 in a teaching hospital from Tunisia. [PDF]

JAC Antimicrob Resist
Jaidane N, Mansour W, Oueslati S, Mehidi I, Al Laham N, Lazzem A, Berriri A, Ben Lamine Y, Trabelsi A, Dortet L, Naija W, Bonnin RA, Iorga BI, Tilouche L, Naas T.   +14 more
europepmc   +1 more source

Effects of phage-based treatments against an OXA-48-producing Klebsiella pneumoniae isolate in simulated human gut microbiomes. [PDF]

BMC Microbiol
Ferriol-González C, Hernanz-Grimalt A, Valdivia C, García-Cobos S, Heredia A, García-Hernández J, Andrés A, Domingo-Calap P.   +7 more
europepmc   +1 more source